Literature DB >> 2000935

Development of intrapancreatic transplantable model of pancreatic duct adenocarcinoma in Syrian golden hamsters.

H Egami1, T Tomioka, M Tempero, D Kay, P M Pour.   

Abstract

Intrapancreatic and subcutaneous (SC) inoculation of cultured pancreatic cancer cells, derived from an induced primary pancreatic cancer in a Syrian hamster, resulted in tumor take in all recipient hamsters. The intrapancreatic allografts grew rapidly, were invasive, and metastasized into the lymph nodes and liver in 2 of 9 cases. In comparison, SC tumors grew relatively slower and formed a large encapsulated mass without invasion and metastases. Histologically, tumors of both sites showed fairly well-differentiated adenocarcinomas of ductal/ductular type resembling the induced primary cancer. Similar to the primary induced pancreatic cancers, tumor cells of both allografts expressed blood-group-related antigens, including A, B, H, Le(b), Le(y), Le(x), and tumor-associated antigen TAG-72. The tumor cells did not express Le(a), CA 19-9, 17-1A, or DU-PAN-2. The expression of these antigens was retained in the metastases and presented the same patterns of reactivity as the allografts. Thus intrapancreatic transplantation provides a rapid model for production of pancreatic cancer with morphologic similarities to human pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2000935      PMCID: PMC1886266     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

1.  Transplantable ductal adenocarcinoma of the Syrian hamster pancreas.

Authors:  D G Scarpelli; M S Rao
Journal:  Cancer Res       Date:  1979-02       Impact factor: 12.701

2.  Expression of human tumor-associated antigens in pancreatic cancer induced in Syrian hamsters.

Authors:  Y Takiyama; H Egami; P M Pour
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

3.  Monoclonal antibodies directed against the human Leb blood group antigen.

Authors:  M Brockhaus; J L Magnani; M Blaszczyk; Z Steplewski; H Koprowski; K A Karlsson; G Larson; V Ginsburg
Journal:  J Biol Chem       Date:  1981-12-25       Impact factor: 5.157

4.  Development of a transplantable model of pancreatic duct adenocarcinoma.

Authors:  C M Townsend; R B Franklin; F B Gelder; E Glass; J C Thompson
Journal:  Surgery       Date:  1982-07       Impact factor: 3.982

5.  A spectrum of monoclonal antibodies reactive with human mammary tumor cells.

Authors:  D Colcher; P H Hand; M Nuti; J Schlom
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

6.  Nitrosamine-induced transplantable pancreatic ductal adenocarcinoma in inbred Syrian hamsters.

Authors:  W F Sindelar; C C Kurman
Journal:  J Natl Cancer Inst       Date:  1981-11       Impact factor: 13.506

7.  The morphologic and biologic patterns of chemically induced pancreatic adenocarcinoma in Syrian golden hamsters after homologous transplantation.

Authors:  M Takahashi; R Runge; T Donnelly; P Pour
Journal:  Cancer Lett       Date:  1979-07       Impact factor: 8.679

8.  Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies.

Authors:  R S Metzgar; M T Gaillard; S J Levine; F L Tuck; E H Bossen; M J Borowitz
Journal:  Cancer Res       Date:  1982-02       Impact factor: 12.701

9.  Reactivity of a monoclonal antibody with human ovarian carcinoma.

Authors:  R C Bast; M Feeney; H Lazarus; L M Nadler; R B Colvin; R C Knapp
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

10.  Current knowledge of pancreatic carcinogenesis in the hamster and its relevance to the human disease.

Authors:  P M Pour; R G Runge; D Birt; R Gingell; T Lawson; D Nagel; L Wallcave; S Z Salmasi
Journal:  Cancer       Date:  1981-03-15       Impact factor: 6.860

View more
  13 in total

1.  Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238.

Authors:  N Benali; P Cordelier; D Calise; P Pages; P Rochaix; A Nagy; J P Esteve; P M Pour; A V Schally; N Vaysse; C Susini; L Buscail
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

2.  Investigational Strategies for Detection and Intervention in Early-Stage Pancreatic Cancer. April 24-27, Annapolis, Maryland. Abstracts.

Authors: 
Journal:  Int J Pancreatol       Date:  1994 Oct-Dec

3.  MicroRNA-221 induces autophagy through suppressing HDAC6 expression and promoting apoptosis in pancreatic cancer.

Authors:  Yifan Yang; Yang Sun; Huaitao Wang; Hansi Li; Mingjie Zhang; Lei Zhou; Xiangli Meng; Yunhao Wu; Peng Liu; Xin Liu; Jun Zhang; Xiaodong Tan
Journal:  Oncol Lett       Date:  2018-09-27       Impact factor: 2.967

4.  Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway.

Authors:  X Tan; H Egami; M Abe; F Nozawa; M Hirota; M Ogawa
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

5.  Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol.

Authors:  Y D Burke; M J Stark; S L Roach; S E Sen; P L Crowell
Journal:  Lipids       Date:  1997-02       Impact factor: 1.880

6.  Establishment of a transplantable carcinoma arising from the intrahepatic bile duct in Syrian golden hamsters.

Authors:  T Fukahori; T Tomioka; K Inoue; Y Tajima; T Tsunoda; T Kanematsu
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

7.  Use of H19 Gene Regulatory Sequences in DNA-Based Therapy for Pancreatic Cancer.

Authors:  V Scaiewicz; V Sorin; Y Fellig; T Birman; A Mizrahi; J Galula; R Abu-Lail; T Shneider; P Ohana; L Buscail; A Hochberg; A Czerniak
Journal:  J Oncol       Date:  2010-10-28       Impact factor: 4.375

8.  Differential expression profiles of microRNAs in highly and weakly invasive/metastatic pancreatic cancer cells.

Authors:  Xiaodong Tan; Lei Zhou; Huaitao Wang; Yifan Yang; Yang Sun; Zhaoping Wang; Xiaobo Zhang; Feng Gao; Hansi Li
Journal:  Oncol Lett       Date:  2018-08-23       Impact factor: 2.967

9.  Genomic analysis of invasion-metastasis-related factors in pancreatic cancer cells.

Authors:  Xiaodong Tan; Lei Zhou; Wei Wang; Baosheng Wang; Hiroshi Egami; Hideo Baba; Xianwei Dai
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

10.  H19-promoter-targeted therapy combined with gemcitabine in the treatment of pancreatic cancer.

Authors:  Vladimir Sorin; Patricia Ohana; Jennifer Gallula; Tatiana Birman; Imad Matouk; Ayala Hubert; Michal Gilon; Avraham Hochberg; Abraham Czerniak
Journal:  ISRN Oncol       Date:  2012-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.